Pharma Journalist 8887 posts 0 comments

Affinia Therapeutics has received Fast Track designation from the U.S. Food and Drug Administration for its investigational gene therapy candidate AFTX-201, a potential treatment for…
Read More...

Innovative biotech firm Antengene Corporation Limited has entered into a major global licensing agreement with biopharmaceutical company UCB to advance the development of ATG-201, a…
Read More...

Esperion has announced a definitive agreement to acquire Corstasis Therapeutics in a move aimed at strengthening its cardiovascular portfolio and expanding access to innovative…
Read More...

The Ministry of Health, Labour and Welfare has granted orphan drug designation to rilzabrutinib, an investigational oral therapy, for the treatment of IgG4-related disease (IgG4-RD).…
Read More...

Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in Athlone, Ireland, a move aimed at increasing production capacity for…
Read More...

Biotechnology company Sinopia Biosciences, Inc. has entered into a research collaboration with Japanese pharmaceutical firm Ono Pharmaceutical Co., Ltd. to discover new therapeutic…
Read More...

Quotient Sciences has announced an extended commercial supply partnership with Ipsen to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare and…
Read More...

GSK plc has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a new drug application for bepirovirsen, an investigational antisense…
Read More...

GSK plc has announced that China’s drug regulator has accepted its new drug application for linerixibat to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC),…
Read More...

Novo Nordisk and Vivtex Corporation have announced a strategic partnership to develop next-generation oral biologic medicines targeting obesity, diabetes and related metabolic…
Read More...